MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 138 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,530 | +180.2% | 1,476 | +343.2% | 0.00% | – |
| Q2 2023 | $76,923 | +24.0% | 333 | +30.1% | 0.00% | – |
| Q1 2023 | $62,010 | -58.3% | 256 | -50.0% | 0.00% | – |
| Q4 2022 | $148,581 | +132.2% | 512 | -47.6% | 0.00% | – |
| Q3 2022 | $64,000 | -9.9% | 977 | -1.1% | 0.00% | – |
| Q2 2022 | $71,000 | -30.4% | 988 | -4.8% | 0.00% | – |
| Q1 2022 | $102,000 | +30.8% | 1,038 | +11.0% | 0.00% | – |
| Q4 2021 | $78,000 | +11.4% | 935 | +8.0% | 0.00% | – |
| Q3 2021 | $70,000 | +133.3% | 866 | +183.0% | 0.00% | – |
| Q2 2021 | $30,000 | 0.0% | 306 | +17.2% | 0.00% | – |
| Q1 2021 | $30,000 | -16.7% | 261 | -19.4% | 0.00% | – |
| Q4 2020 | $36,000 | +125.0% | 324 | +134.8% | 0.00% | – |
| Q3 2020 | $16,000 | +45.5% | 138 | +38.0% | 0.00% | – |
| Q2 2020 | $11,000 | -68.6% | 100 | -80.9% | 0.00% | – |
| Q1 2020 | $35,000 | – | 523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |